Stronger FDA Warning for Essure
By Paul da Costa on May 31, 2016
Essure is a form of birth control that is implanted into women to be used as a contraceptive. It consists of two nickel-titanium coils inserted into the fallopian tubes to block sperm from fertilizing a woman’s eggs.
There have been many complaints from women who report serious problems, such as chronic pain and bleeding. As there are warning labels regarding pelvic pain and bleeding, some women say it became persistent and very severe that required surgery. However, for some women it has had a positive outcome.
The FDA has not removed this item from the market. They are requiring Bayer, the company who manufacturers Essure, to conduct a study of 2,000 patients comparing their problems and assess its risks in different groups of women. This study should take several years and Bayer should have results by 2017.
As for now, the FDA will be administering a more serious type of warning on the box alerting doctors and patients about problems that have been reported.
Related to This
"I was involved in a VERY complicated and tumultuous child custody, divorce, domestic violence case for two full years. I was fortunate enough to be represented by one of the top matrimonial teams in the state of NJ, and the outcome in my case exceeded my every expectation." - Former Client"Paul personally stood by my side and represented me throughout my injury case. Whether it was business at hand, advice, or a late night phone call to help me understand what was going on; he never took a step back towards helping me. I knew that I could call on him at any time . My case was very successful and I attribute that to Paul's dedication . He even came to me during a snow storm when I could not make it to his office. I certainly would recommend him to anyone." - Former Client